Heart disease remains the leading cause of death in the US, and incurs associated healthcare costs to the tune of over $200 billion annually. Much of it is preventable, and a preventative approach involving frequent, easily accessible health checks may prove lifesaving and ease significant stress on the US healthcare system. This is precisely what Bodyport is hoping to provide, with its remote home monitoring platform which allows users to get immediate access to crucial heart-related bio-measures.
Backing and partnerships for Bodyport come from some high-profile places, including Stanford Medicine and the Y Combinator. This kind of industry and market confidence will likely serve as strong support whilst the company continues developing additional features such as the launch of a virtual cardiac clinic to offer supplementary insights and support users.
In 2022, Bodyport received FDS 510(k) clearance for its Bodyport Cardiac Scale. From here, the company is expanding access and getting closer to its goal of keeping people with fluid management conditions healthier and away from hospitals.
Kirsty
Company Specialist at Welcome to the Jungle